E&G Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $784K | Hold |
2,166
| – | – | 0.15% | 107 |
|
|
2026
Q1 | $762K | Buy |
2,166
+4
| +0.2% | +$1.43K | 0.17% | 103 |
|
|
2025
Q4 | $708K | Hold |
2,162
| – | – | 0.16% | 106 |
|
|
2025
Q3 | $610K | Sell |
2,162
-10
| -0.5% | -$2.9K | 0.14% | 119 |
|
|
2025
Q2 | $606K | Hold |
2,172
| – | – | 0.16% | 118 |
|
|
2025
Q1 | $677K | Sell |
2,172
-200
| -8% | -$59.1K | 0.19% | 106 |
|
|
2024
Q4 | $618K | Sell |
2,372
-100
| -4% | -$29.7K | 0.17% | 108 |
|
|
2024
Q3 | $797K | Buy |
2,472
+200
| +9% | +$65.4K | 0.22% | 92 |
|
|
2024
Q2 | $710K | Hold |
2,272
| – | – | 0.21% | 97 |
|
|
2024
Q1 | $646K | Hold |
2,272
| – | – | 0.2% | 99 |
|
|
2023
Q4 | $654K | Sell |
2,272
-200
| -8% | -$54.5K | 0.23% | 88 |
|
|
2023
Q3 | $664K | Hold |
2,472
| – | – | 0.24% | 89 |
|
|
2023
Q2 | $549K | Sell |
2,472
-125
| -5% | -$29K | 0.19% | 104 |
|
|
2023
Q1 | $628K | Hold |
2,597
| – | – | 0.23% | 92 |
|
|
2022
Q4 | $682K | Sell |
2,597
-200
| -7% | -$53.6K | 0.26% | 87 |
|
|
2022
Q3 | $630K | Hold |
2,797
| – | – | 0.23% | 88 |
|
|
2022
Q2 | $681K | Sell |
2,797
-300
| -10% | -$73.5K | 0.23% | 91 |
|
|
2022
Q1 | $749K | Hold |
3,097
| – | – | 0.2% | 96 |
|
|
2021
Q4 | $697K | Hold |
3,097
| – | – | 0.17% | 110 |
|
|
2021
Q3 | $659K | Buy |
+3,097
| New | +$713K | 0.18% | 107 |
|
|
2021
Q2 | – | Sell |
-3,097
| Closed | -$762K | – | 101 |
|
|
2021
Q1 | $771K | Buy |
3,097
+44
| +1% | +$10.5K | 0.23% | 89 |
|
|
2020
Q4 | $702K | Hold |
3,053
| – | – | 0.22% | 86 |
|
|
2020
Q3 | $776K | Sell |
3,053
-47
| -2% | -$11.6K | 0.27% | 70 |
|
|
2020
Q2 | $731K | Hold |
3,100
| – | – | 0.28% | 73 |
|
|
2020
Q1 | $628K | Buy |
3,100
+100
| +3% | +$21.8K | 0.31% | 70 |
|
|
2019
Q4 | $723K | Sell |
3,000
-400
| -12% | -$88.2K | 0.27% | 87 |
|
|
2019
Q3 | $658K | Hold |
3,400
| – | – | 0.26% | 89 |
|
|
2019
Q2 | $627K | Hold |
3,400
| – | – | 0.27% | 93 |
|
|
2019
Q1 | $646K | Sell |
3,400
-700
| -17% | -$134K | 0.28% | 90 |
|
|
2018
Q4 | $798K | Buy |
4,100
+500
| +14% | +$97.5K | 0.36% | 80 |
|
|
2018
Q3 | $746K | Buy |
3,600
+600
| +20% | +$118K | 0.28% | 86 |
|
|
2018
Q2 | $554K | Sell |
3,000
-400
| -12% | -$70.8K | 0.23% | 107 |
|
|
2018
Q1 | $580K | Buy |
3,400
+900
| +36% | +$165K | 0.25% | 96 |
|
|
2017
Q4 | $435K | Buy |
2,500
+600
| +32% | +$106K | 0.18% | 118 |
|
|
2017
Q3 | $354K | Buy |
+1,900
| New | +$337K | 0.16% | 120 |
|
Other funds holding AMGN
E&G Advisors's AMGN Position: Q2 2026 in Review
E&G Advisors held its Amgen (AMGN) position steady in Q2 2026 at 2,166 shares worth $784K. The position accounts for 0.15% of the portfolio, ranked #107.
E&G Advisors first reported a position in AMGN in Q3 2017 and has held it in 35 quarters since. The position peaked at $798K in Q4 2018. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- E&G Advisors held 2,166 shares of Amgen worth $784K as of Q2 2026.
- E&G Advisors left its Amgen share count unchanged in Q2 2026.
- Amgen made up 0.15% of E&G Advisors's portfolio in Q2 2026, its #107 holding.
- E&G Advisors first reported a position in Amgen in Q3 2017 and has held it in 35 quarters since.
- E&G Advisors's Amgen position peaked at $798K in Q4 2018.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on E&G Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.